Your User Name is:
TSRO ASTRO Istanbul eContouring March17, 2018 (AI)Advanced Session: Case 1: T4 N1 M0 nasopharyngeal carcinoma (EBV/HPV negative)Contour Homework:CORD on slices 56, 57, 58, 59, 60, 61, 62LIPS on slices 55, 56, 57, 58, 59, 60, 61, 62, 63LARYNX on slices 78, 79, 80ORAL_CAVITY on slices 62, 63, 64PAROTID_L on slices 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61PAROTID_R on slices 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61SUBMAND_L on slices 70, 71, 72, 73SUBMAND_R on slices 70, 71, 72, 73Spinal kord 56-62 Dudaklar 55-63 oral kavite 62-64 larinks 78-80 parotis 51-61 submandibuler bez 70-73Disabled Contours: All Except for GTVs Enabled Contours: GTVResource Files:Demo Training Video: How to contour, complete the homework, and save/submit 02 Nazofarinks Turkish Homework and VignetteNazofarinks_AE_HN_Vignette_IES_Turkey_2016.pdf EduCase User Guide
Sunday, September 24, 2017, 1:15 p.m. - 2:45 p.m. eContouring for Head and Neck Course I: Matthew Stenmark, MD, Sue Yom, MD, Suresh Mukherji, MD, MBA, FACRHomework:CTV1 on slices 49, 56, 63, 66, 71, 77, 80, 86, 90, 95 CTV2 on slices 49, 56, 63, 66, 71, 77, 80, 85, 90, 95 CTV3 on slices 49, 56, 63, 66, 71, 77, 80, 85, 90, 95Disabled Contours: GTV enabledEnabled Contours: All others disabledResource Files:Right tonsil VignetteEduCase User Guide
Sunday, September 24, 2017, 1:15 p.m. - 2:45 p.m. eContouring for Head and Neck Course I: Matthew Stenmark, MD, Sue Yom, MD, Suresh Mukherji, MD, MBA, FACRContour Homework:The GTVs have been defined for you based on physical examination and the pre-treatment imaging (CT, PET-CT, and MR).Assuming a 30 fraction treatment, please use the treatment planning CT to define:Clinical target volumes, selecting from the following dose levels. You may use as many or as few as you see appropriate. CTV_66 Gy (2.2 Gy/fx) CTV_60 Gy (2.0 Gy/fx) CTV_57 Gy (1.9 Gy/fx) CTV_54 Gy (1.8 Gy/fx) CTV_51 Gy (1.7 Gy/fx)Organs at risk Contour as many or as few as you see appropriate on slices: 54, 58, 62, 66, 70, 74, 78, 82, 86, 90, 94, 98, 102(homework icons not engaged in UI)Enabled Reference Contours: All GTVsDisabled Contours: All Except for GTVsResource Files:Unknown primary VignetteEduCase User Guide
TSRO ASTRO Istanbul eContouring May 27, 2017 (9 AM-4 PM), in American Hospital, IstanbulAdvanced Session: Case 1: T4 N1 M0 nasopharyngeal carcinoma (EBV/HPV negative)Contour Homework: The GTVs have been defined for you based on physical examination and the pre-treatment imaging (CT and PET-CT). Please contour the following on the treatment planning CT:1. CTV1: CTV for gross disease2. CTV2: CTV for high-risk subclinical disease3. CTV3: CTV for low-risk subclinical diseasePlease contour these structures on images: 40, 46, 49, 56, 59, 67, 74, 85, 95 Disabled Contours: All Except for GTVs Enabled Contours: All GTVs Resource Files: Nazofarinks_AE_HN_Vignette_IES_Turkey_2016.pdf EduCase User Guide
TSRO ASTRO Istanbul eContouring May 27, 2017 (9 AM-4 PM), in American Hospital, IstanbulIntermediate Session: Case 2 – T2 N1 M0 poorly differentiated squamous cell carcinoma of the base of tongue, HPV positiveContour Homework: The GTVs have been defined for you based on physical examination and the pre-treatment imaging (CT and PET-CT). Please contour the following on the treatment planning CT: 1. CTV1: CTV for gross disease2. CTV2: CTV for high-risk subclinical disease3. CTV3: CTV for low-risk subclinical disease
Please contour these structures on images: 57, 64, 68, 72, 76, 84, 90, 98 Disabled Contours: All Except for GTVs Enabled Contours: All GTVs Resource Files: Dilkoku AE HN Int02 Vignette IES Turkey 2016.pdf EduCase User Guide
Sunday, September 25, 2016 10:30 a.m. - 12:00 p.m. eContouring for Head and Neck –Intermediate (Avraham Eisbruch, MD, FASTRO Matthew Stenmark, MD, Suresh Mukherji, MD, MBA, FACR, and Sue S. Yom, MD, PhD)Intermediate Session: Case 1 – T1 N2a M0 poorly differentiated squamous cell carcinoma of the right tonsil, HPV positiveContour Homework: The GTVs have been defined for you based on physical examination and the pre-treatment imaging (CT and PET-CT). Please contour the following on the treatment planning CT: 1. CTV1: CTV for gross disease 2. CTV2: CTV for high-risk subclinical disease 3. CTV3: CTV for low-risk subclinical disease 4. OAR: Relevant organs at risk (many are listed in the structure set). Please contour these structures on images: 49, 56, 63, 66, 71, 77, 80, 85, 90, 95Disabled Contours: All Except for GTVs Enabled Contours: All GTVs Resource Files: AE HN Int01 Vignette 2016.pdf EduCase User Guide
Sunday, September 25, 2016 10:30 a.m. - 12:00 p.m. eContouring for Head and Neck –Intermediate (Avraham Eisbruch, MD, FASTRO Matthew Stenmark, MD, Suresh Mukherji, MD, MBA, FACR, and Sue S. Yom, MD, PhD)Intermediate Session: Case 2 – T2 N1 M0 poorly differentiated squamous cell carcinoma of the base of tongue, HPV positiveContour Homework: The GTVs have been defined for you based on physical examination and the pre-treatment imaging (CT and PET-CT). Please contour the following on the treatment planning CT: 1. CTV1: CTV for gross disease 2. CTV2: CTV for high-risk subclinical disease 3. CTV3: CTV for low-risk subclinical disease 4. OAR: Relevant organs at risk (many are listed in the structure set). Please contour these structures on images: 52, 57, 64, 68, 70, 72, 76, 79, 84, 90, 98 Disabled Contours: All Except for GTVs Enabled Contours: All GTVs Resource Files: AE HN Int02 Vignette 2016.pdf EduCase User Guide
Pre-Congress Session: E-CONTOURING SESSIONVenue: AMETHYST ROOM, MANILA DIAMOND HOTEL, ROXAS BLVD MANILATime: 8am - 3pmSessions in Charge: MISAEL C. CRUZ, MD, MacFaculty: KENNETH HU, MD, DENNIS DOROMAL MD, GONZALO BANUELOS MD, MISAEL CRUZ MDContour Homework: The GTVs have been defined for you based on physical examination and the pre-treatment imaging (CT and PET-CT). Please contour the following on the treatment planning CT: CTV1 on slices 49, 56, 63, 66, 71, 77, 80, 85, 90, 95 CTV2 on slices 49, 56, 63, 66, 71, 77, 80, 85, 90, 95 CTV3 on slices 49, 56, 63, 66, 71, 77, 80, 85, 90, 95 Optional: OAR: Relevant organs at risk (many are listed in the structure set)Disabled Contours: All Except for GTVs Enabled Contours: All GTVs Resource Files: AE HN Int01 Vignette 2016.pdf EduCase User Guide
Pre-Congress Session: E-CONTOURING SESSIONVenue: AMETHYST ROOM, MANILA DIAMOND HOTEL, ROXAS BLVD MANILATime: 8am - 3pmSessions in Charge: MISAEL C. CRUZ, MD, MacFaculty: KENNETH HU, MD, DENNIS DOROMAL MD, GONZALO BANUELOS MD, MISAEL CRUZ MDContour Homework: The GTVs have been defined for you based on physical examination and the pre-treatment imaging (CT and PET-CT). Please contour the following on the treatment planning CT: CTV1 on slices 40, 43, 46, 49, 52, 56, 59, 63, 67, 70, 74, 78, 85, 90, 95CTV2 on slices 40, 43, 46, 49, 52, 56, 59, 63, 67, 70, 74, 78, 85, 90, 95CTV3 on slices 40, 43, 46, 49, 52, 56, 59, 63, 67, 70, 74, 78, 85, 90, 95Optional: OAR: Relevant organs at risk (many are listed in the structure set).Disabled Contours: All Except for GTVs Enabled Contours: All GTVs Resource Files: AE HN Adv01 Vignette 2016.pdf EduCase User Guide
TSRO - eContouring: Saturday, September 3rd, 2016Intermediate Session: Case 2 – T2 N1 M0 poorly differentiated squamous cell carcinoma of the base of tongue, HPV positiveContour Homework: The GTVs have been defined for you based on physical examination and the pre-treatment imaging (CT and PET-CT). Please contour the following on the treatment planning CT: 1. CTV1: CTV for gross disease2. CTV2: CTV for high-risk subclinical disease3. CTV3: CTV for low-risk subclinical disease
TSRO - eContouring: Saturday, September 3rd, 2016Advanced Session: Case 1: T4 N1 M0 nasopharyngeal carcinoma (EBV/HPV negative)Contour Homework: The GTVs have been defined for you based on physical examination and the pre-treatment imaging (CT and PET-CT). Please contour the following on the treatment planning CT:1. CTV1: CTV for gross disease2. CTV2: CTV for high-risk subclinical disease3. CTV3: CTV for low-risk subclinical diseasePlease contour these structures on images: 40, 46, 49, 56, 59, 67, 74, 85, 95 Disabled Contours: All Except for GTVs Enabled Contours: All GTVs Resource Files: Nazofarinks_AE_HN_Vignette_IES_Turkey_2016.pdf EduCase User Guide
ASTRO – Turkey - eContouring: Saturday, March 12th, 2016Intermediate Session: Case 2 – T2 N1 M0 poorly differentiated squamous cell carcinoma of the base of tongue, HPV positiveContour Homework: The GTVs have been defined for you based on physical examination and the pre-treatment imaging (CT and PET-CT). Please contour the following on the treatment planning CT: 1. CTV1: CTV for gross disease2. CTV2: CTV for high-risk subclinical disease3. CTV3: CTV for low-risk subclinical disease
ASTRO – Turkey - eContouring: Saturday, March 12th, 2016Advanced Session: Case 1: T4 N1 M0 nasopharyngeal carcinoma (EBV/HPV negative)Contour Homework: The GTVs have been defined for you based on physical examination and the pre-treatment imaging (CT and PET-CT). Please contour the following on the treatment planning CT:1. CTV1: CTV for gross disease2. CTV2: CTV for high-risk subclinical disease3. CTV3: CTV for low-risk subclinical diseasePlease contour these structures on images: 40, 46, 49, 56, 59, 67, 74, 85, 95 Disabled Contours: All Except for GTVs Enabled Contours: All GTVs Resource Files: Nazofarinks_AE_HN_Vignette_IES_Turkey_2016.pdf EduCase User Guide
Sunday, October 18, 2015 10:30 a.m. - 12:00 p.m. Head and Neck – Intermediate Faculty: Avraham Eisbruch, MD, Matthew Stenmark, MD, Suresh Mukherji, MDIntermediate Session: Case 1 – T1 N2a M0 poorly differentiated squamous cell carcinoma of the right tonsil, HPV positiveContour Homework: The GTVs have been defined for you based on physical examination and the pre-treatment imaging (CT and PET-CT). Please contour the following on the treatment planning CT: 1. CTV1: CTV for gross disease 2. CTV2: CTV for high-risk subclinical disease 3. CTV3: CTV for low-risk subclinical disease 4. OAR: Relevant organs at risk (many are listed in the structure set). Please contour these structures on images: 49, 56, 63, 66, 71, 77, 80, 85, 90, 95Disabled Contours: All Except for GTVs Enabled Contours: All GTVs Resource Files: AE HN Int01 Vignette 2015.pdf EduCase User Guide
Sunday, October 18, 2015 10:30 a.m. - 12:00 p.m. Head and Neck – Intermediate Faculty: Avraham Eisbruch, MD, Matthew Stenmark, MD, Suresh Mukherji, MDIntermediate Session: Case 2 – T2 N1 M0 poorly differentiated squamous cell carcinoma of the base of tongue, HPV positiveContour Homework: The GTVs have been defined for you based on physical examination and the pre-treatment imaging (CT and PET-CT). Please contour the following on the treatment planning CT: 1. CTV1: CTV for gross disease 2. CTV2: CTV for high-risk subclinical disease 3. CTV3: CTV for low-risk subclinical disease 4. OAR: Relevant organs at risk (many are listed in the structure set). Please contour these structures on images: 52, 57, 64, 68, 70, 72, 76, 79, 84, 90, 98 Disabled Contours: All Except for GTVs Enabled Contours: All GTVs Resource Files: AE HN Int02 Vignette 2015.pdf EduCase User Guide
Sunday, October 18, 2015 1:15 p.m. - 2:45 p.m. Head and Neck - Advanced Faculty: Avraham Eisbruch, MD, Matthew Stenmark, MD, Suresh Mukherji, MDAdvanced Session: Case 1: T4 N1 M0 nasopharyngeal carcinoma (EBV/HPV negative)Contour Homework: The GTVs have been defined for you based on physical examination and the pre-treatment imaging (CT and PET-CT). Please contour the following on the treatment planning CT: 1. CTV1: CTV for gross disease 2. CTV2: CTV for high-risk subclinical disease 3. CTV3: CTV for low-risk subclinical disease 4. OAR: Relevant organs at risk (many are listed in the structure set).Please contour these structures on images: 40, 43, 46, 49, 52, 56, 59, 63, 67, 70, 74, 78, 85, 90, 95 Disabled Contours: All Except for GTVs Enabled Contours: All GTVs Resource Files: AE HN Adv01 Vignette 2015.pdf EduCase User Guide
Sunday, October 18, 2015 1:15 p.m. - 2:45 p.m. Head and Neck - Advanced Faculty: Avraham Eisbruch, MD, Matthew Stenmark, MD, Suresh Mukherji, MDAdvanced Session: Case 2: Recurrent cutaneous squamous cell carcinoma of the left templeContour Homework:Please contour the following on the treatment planning CT: GTV: Gross tumor volumes CTV1: CTV for gross disease CTV2: CTV for high-risk subclinical disease CTV3: CTV for low-risk subclinical disease OAR: Relevant organs at risk (many are listed in the structure set). Please contour these structures on images: 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58 Disabled Contours: AllEnabled Contours: None Resource Files: AE HN Adv02 Vignette 2015.pdf EduCase User Guide
Intermediate Session: Case 1 – T1 N2a M0 poorly differentiated squamous cell carcinoma of the right tonsil, HPV positiveContour Homework: The GTVs have been defined for you based on physical examination and the pre-treatment imaging (CT and PET-CT). Please contour the following on the treatment planning CT: 1. CTV1: CTV for gross disease 2. CTV2: CTV for high-risk subclinical disease 3. CTV3: CTV for low-risk subclinical disease 4. OAR: Relevant organs at risk (many are listed in the structure set). Please contour these structures on images: 49, 56, 63, 66, 71, 77, 80, 85, 90, 95Disabled Contours: All Except for GTVs Enabled Contours: All GTVs Resource Files: AE_HN_Int01_Vingette.pdf EduCase User Guide
Intermediate Session: Case 2 – T2 N1 M0 poorly differentiated squamous cell carcinoma of the base of tongue, HPV positiveContour Homework: The GTVs have been defined for you based on physical examination and the pre-treatment imaging (CT and PET-CT). Please contour the following on the treatment planning CT: 1. CTV1: CTV for gross disease 2. CTV2: CTV for high-risk subclinical disease 3. CTV3: CTV for low-risk subclinical disease 4. OAR: Relevant organs at risk (many are listed in the structure set). Please contour these structures on images: 52, 57, 64, 68, 70, 72, 76, 79, 84, 90, 98 Disabled Contours: All Except for GTVs Enabled Contours: All GTVs Resource Files: AE_HN_Int02_Vingette.pdf EduCase User Guide
Advanced Session: Case 1: T4 N1 M0 nasopharyngeal carcinoma (EBV/HPV negative)Contour Homework: The GTVs have been defined for you based on physical examination and the pre-treatment imaging (CT and PET-CT). Please contour the following on the treatment planning CT: 1. CTV1: CTV for gross disease 2. CTV2: CTV for high-risk subclinical disease 3. CTV3: CTV for low-risk subclinical disease 4. OAR: Relevant organs at risk (many are listed in the structure set).Please contour these structures on images: 40, 43, 46, 49, 52, 56, 59, 63, 67, 70, 74, 78, 85, 90, 95 Disabled Contours: All Except for GTVs Enabled Contours: All GTVs Resource Files: AE_HN_Adv01_Vingette.pdf EduCase User Guide
Advanced Session: Case 2: Recurrent cutaneous squamous cell carcinoma of the left templeContour Homework:Please contour the following on the treatment planning CT: GTV: Gross tumor volumes CTV1: CTV for gross disease CTV2: CTV for high-risk subclinical disease CTV3: CTV for low-risk subclinical disease OAR: Relevant organs at risk (many are listed in the structure set). Please contour these structures on images: 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58 Disabled Contours: AllEnabled Contours: None Resource Files: AE_HN_Adv02_Vingette.pdf EduCase User Guide
Intermediate Session: Case 1 – T1 N2a M0 poorly differentiated squamous cell carcinoma of the right tonsil, HPV positiveSunday, September 14, 2014, 1:15 p.m. - 2:45 p.m., eContouring for Head and Neck –Intermediate, Avraham Eisbruch, MD, Matthew Stenmark, MD and Mary Beth Cunnane, MDContour Homework: The GTVs have been defined for you based on physical examination and the pre-treatment imaging (CT and PET-CT). Please contour the following on the treatment planning CT: 1. CTV1: CTV for gross disease 2. CTV2: CTV for high-risk subclinical disease 3. CTV3: CTV for low-risk subclinical disease 4. OAR: Relevant organs at risk (many are listed in the structure set). Please contour these structures on images: 49, 56, 63, 66, 71, 77, 80, 85, 90, 95Disabled Contours: All Except for GTVs Enabled Contours: All GTVs Resource Files:AE_HN_Int01_Vingette.pdfEduCase User Guide
Intermediate Session: Case 2 – T2 N1 M0 poorly differentiated squamous cell carcinoma of the base of tongue, HPV positiveSunday, September 14, 2014, 1:15 p.m. - 2:45 p.m., eContouring for Head and Neck –Intermediate, Avraham Eisbruch, MD, Matthew Stenmark, MD and Mary Beth Cunnane, MDContour Homework: The GTVs have been defined for you based on physical examination and the pre-treatment imaging (CT and PET-CT). Please contour the following on the treatment planning CT: 1. CTV1: CTV for gross disease 2. CTV2: CTV for high-risk subclinical disease 3. CTV3: CTV for low-risk subclinical disease 4. OAR: Relevant organs at risk (many are listed in the structure set). Please contour these structures on images: 52, 57, 64, 68, 70, 72, 76, 79, 84, 90, 98 Disabled Contours: All Except for GTVs Enabled Contours: All GTVs Resource Files:AE_HN_Adv02_Vingette.pdfEduCase User Guide
Advanced Session: Case 1: T4 N1 M0 nasopharyngeal carcinoma (EBV/HPV negative)Sunday, September 14, 2014, 3:00 p.m. - 4:30 p.m., eContouring for Head and Neck - Advanced, Avraham Eisbruch, MD, Matthew Stenmark, MD and Mary Beth Cunnane, MDContour Homework: The GTVs have been defined for you based on physical examination and the pre-treatment imaging (CT and PET-CT). Please contour the following on the treatment planning CT: 1. CTV1: CTV for gross disease 2. CTV2: CTV for high-risk subclinical disease 3. CTV3: CTV for low-risk subclinical disease 4. OAR: Relevant organs at risk (many are listed in the structure set).Please contour these structures on images: 40, 43, 46, 49, 52, 56, 59, 63, 67, 70, 74, 78, 85, 90, 95 Disabled Contours: All Except for GTVs Enabled Contours: All GTVs Resource Files:AE_HN_Adv01_Vingette.pdfEduCase User Guide
Advanced Session: Case 2: Recurrent cutaneous squamous cell carcinoma of the left templeSunday, September 14, 2014, 3:00 p.m. - 4:30 p.m., eContouring for Head and Neck - Advanced, Avraham Eisbruch, MD, Matthew Stenmark, MD and Mary Beth Cunnane, MDContour Homework:Please contour the following on the treatment planning CT: GTV: Gross tumor volumes CTV1: CTV for gross disease CTV2: CTV for high-risk subclinical disease CTV3: CTV for low-risk subclinical disease OAR: Relevant organs at risk (many are listed in the structure set). Please contour these structures on images: 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58 Disabled Contours: AllEnabled Contours: None Resource Files:AE_HN_Adv02_Vingette.pdfEduCase User Guide
